Merck buying Acceleron Pharma in $11.5B deal

Published September 30, 2021 4:11 AM

The Associated Press

KENILWORTH, New Jersey (AP) — Merck will spend about $11.5 billion to acquire Acceleron Pharma and it’s treatment for high pressure in vessels that carry blood to the lungs from the heart. Merck will pay $180 per share in cash for each Acceleron share, the Kenilworth, New Jersey, company said Thursday. The deal is expected to close in the fourth quarter.

Article Topic Follows: AP National Business

Jump to comments ↓

Associated Press

BE PART OF THE CONVERSATION

News Channel 3 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.